123 related articles for article (PubMed ID: 29218103)
1. MicroRNA-429 sensitizes pancreatic cancer cells to gemcitabine through regulation of PDCD4.
Yu G; Jia B; Cheng Y; Zhou L; Qian B; Liu Z; Wang Y
Am J Transl Res; 2017; 9(11):5048-5055. PubMed ID: 29218103
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine.
Yu Y; Ding F; Gao M; Jia YF; Ren L
Oncol Lett; 2019 Sep; 18(3):3065-3071. PubMed ID: 31452783
[TBL] [Abstract][Full Text] [Related]
3. [Establish a gemcitabine-resistant pancreatic cancer cell line SW1990/GZ and research the relationship between SW1990/GZ and pancreatic cancer stem cell].
An Y; Yao J; Wei JS; Lu ZP; Cai HH; Dai CC; Qian ZY; Xu ZK; Miao Y
Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):999-1003. PubMed ID: 21054984
[TBL] [Abstract][Full Text] [Related]
4. [MiR-183 Regulates Proliferation of SW1990 Pancreatic Cancer Cell Line by Targeting PDCD4].
Lu YY; Zeng Y; Zheng JY; Huang CL; Wang XP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 47(5):691-696. PubMed ID: 28598081
[TBL] [Abstract][Full Text] [Related]
5. miR-183 induces cell proliferation, migration, and invasion by regulating PDCD4 expression in the SW1990 pancreatic cancer cell line.
Lu YY; Zheng JY; Liu J; Huang CL; Zhang W; Zeng Y
Biomed Pharmacother; 2015 Mar; 70():151-7. PubMed ID: 25776494
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN.
Xia X; Zhang K; Luo G; Cen G; Cao J; Huang K; Qiu Z
Am J Transl Res; 2017; 9(4):1886-1895. PubMed ID: 28469793
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1.
Cheng D; Xu Y; Sun C; He Z
Mol Cell Biochem; 2016 Dec; 423(1-2):85-91. PubMed ID: 27686452
[TBL] [Abstract][Full Text] [Related]
8. [A pilot study on the impact of the drug resistance on the radioresistance in human pancreatic cancer cell lines].
Chen G; Zhao YP; Jiang H; Guo JC; Zhang LY; Niu BZ; Wu WW
Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(13):921-3. PubMed ID: 17067488
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma.
Zhou L; Jia S; Ding G; Zhang M; Yu W; Wu Z; Cao L
J Cancer; 2019; 10(21):5031-5040. PubMed ID: 31602254
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of NEAT1 sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine through modulation of the miR-506-3p/ZEB2/EMT axis.
Fu X; Deng X; Xiao W; Huang B; Yi X; Zou Y
Am J Cancer Res; 2021; 11(8):3841-3856. PubMed ID: 34522453
[TBL] [Abstract][Full Text] [Related]
11. Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition.
Wei W; Wang J; Hu Y; Chen S; Liu J
Exp Ther Med; 2023 Jan; 25(1):7. PubMed ID: 36545274
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-320a promotes 5-FU resistance in human pancreatic cancer cells.
Wang W; Zhao L; Wei X; Wang L; Liu S; Yang Y; Wang F; Sun G; Zhang J; Ma Y; Zhao Y; Yu J
Sci Rep; 2016 Jun; 6():27641. PubMed ID: 27279541
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.
Xiong J; Wang D; Wei A; Ke N; Wang Y; Tang J; He S; Hu W; Liu X
Oncotarget; 2017 Dec; 8(64):107500-107512. PubMed ID: 29296182
[TBL] [Abstract][Full Text] [Related]
14. MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial-Mesenchymal Transition.
Wei W; Wang L; Xu L; Liang J; Teng L
ACS Omega; 2021 Nov; 6(47):31435-31446. PubMed ID: 34869970
[TBL] [Abstract][Full Text] [Related]
15. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
Tao L; Wu YQ; Zhang SP
Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
[TBL] [Abstract][Full Text] [Related]
16. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-7 modulates cellular senescence to relieve gemcitabine resistance by targeting PARP1/NF-κB signaling in pancreatic cancer cells.
Ye ZQ; Chen HB; Zhang TY; Chen Z; Tian L; Gu DN
Oncol Lett; 2021 Feb; 21(2):139. PubMed ID: 33552258
[TBL] [Abstract][Full Text] [Related]
18. A Feedback Loop between MicroRNA 155 (miR-155), Programmed Cell Death 4, and Activation Protein 1 Modulates the Expression of miR-155 and Tumorigenesis in Tongue Cancer.
Zargar S; Tomar V; Shyamsundar V; Vijayalakshmi R; Somasundaram K; Karunagaran D
Mol Cell Biol; 2019 Mar; 39(6):. PubMed ID: 30617160
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of miR-141 reverses cisplatin resistance in non-small cell lung cancer cells via upregulation of programmed cell death protein 4.
Fu WF; Chen WB; Dai L; Yang GP; Jiang ZY; Pan L; Zhao J; Chen G
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(12):2565-72. PubMed ID: 27383306
[TBL] [Abstract][Full Text] [Related]
20. Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.
Zhao Y; Zhao L; Ischenko I; Bao Q; Schwarz B; Nieß H; Wang Y; Renner A; Mysliwietz J; Jauch KW; Nelson PJ; Ellwart JW; Bruns CJ; Camaj P
Target Oncol; 2015 Dec; 10(4):535-48. PubMed ID: 25639539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
